Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 1.02B | £ 1.22B | £ 1.20B | £ 1.26B | £ 1.20B |
Total Assets | £ 3.73B | £ 3.70B | £ 3.58B | £ 3.50B | £ 3.62B |
Total Debt | £ 1.51B | £ 1.40B | £ 1.42B | £ 1.36B | £ 1.75B |
Net Debt | £ 496.00M | £ 179.00M | £ 224.70M | £ 101.00M | £ 549.90M |
Total Liabilities | £ 2.20B | £ 2.08B | £ 2.04B | £ 1.94B | £ 2.35B |
Stockholders Equity | £ 1.52B | £ 1.61B | £ 1.53B | £ 1.56B | £ 1.27B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |